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Abstract
Background: A key event in transmissible spongiform encephalopathies (TSEs) is the conversion of the soluble, protease-
sensitive glycosylated prion protein (PrP
C) to an abnormally structured, aggregated and partially protease-resistant isoform
(PrP
Sc). Both PrP isoforms bear two potential glycosylation sites and thus in a typical western blot with an anti-PrP antibody
three distinct bands appear, corresponding to the di-, mono- or unglycosylated forms of the protein. The relative intensity
and electrophoretic mobility of the three bands are characteristic of each TSE strain and have been used to discriminate
between them.
Methodology/Principal Findings: In the present study we used lectin-based western blotting to evaluate possible
variations in composition within sugar chains carried by PrP
Sc purified from subjects affected with different TSEs. Our
findings indicate that in addition to the already well-documented differences in electrophoretic mobility and amounts of
the glycosylated PrP
Sc forms, TSE strains also vary in the abundance of specific N-linked sugars of the PrP
Sc protein.
Conclusions/Significance: These results imply that PrP glycosylation might fine-tune the conversion of PrP
C to PrP
Sc and
could play an accessory role in the appearance of some of the characteristic features of TSE strains. The differences in sugar
composition could also be used as an additional tool for discrimination between the various TSEs.
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Introduction
Transmissible Spongiform Encephalopathies (TSEs) are invari-
ably fatal neurodegenerative diseases affecting both humans and
animals. TSEs include sporadic and variant Creutzfeldt Jakob
Disease (sCJD, vCJD) in humans, scrapie (Sc) in sheep and goats
and bovine spongiform encephalopathy (BSE) in cattle. The
common pathogen to all TSEs is the ‘prion’, the major component
of which is an abnormal isoform (PrP
Sc) of the cellular prion
protein (PrP
C). It is believed that upon prion infection, PrP
Sc elicits
the conversion of PrP
C to the abnormal conformer [1]. The two
isoforms share the same primary structure, but differ in the
secondary; PrP
Sc consists mainly of b-pleated sheet [2], while PrP
C
contains a two-stranded antiparallel beta-sheet and three alpha-
helices [3,4]. Unlike PrP
C, PrP
Sc is partially detergent insoluble,
protease- and heat-resistant [5] and a large proportion of its
methionine residues is sulfoxided [6].
PrP consists of a single polypeptide chain which is attached to
the cell surface by a glycosylphosphatidylinositol (GPI) anchor at
its carboxyl terminus [7] and bears two highly conserved N-
glycosylation sites [8]. Depending on the extent of glycosylation,
the mature prion protein can be unglycosylated, mono- or
diglycosylated. TSE strains display differences in abundance and
electrophoretic mobility of the proteinase K (PK) resistant forms of
PrP
Sc glycoforms and these differences have been used extensively
as a method to discriminate between the various TSE strains,
through a process known as glycotyping [9–11].
Glycosylation is a major contributor to prion protein’s
heterogeneity; numerous PrP
Sc subpopulations differing in N-
linked glycans have been identified when PrP
Sc populations
purified from hamster [12,13] or murine [14] brains were
analyzed. Similarly, heterogeneity in the GPI anchor composition
has also been observed [15].
PrP
C and PrP
Sc contain different but overlapping sets of glycan
structures. The proportion of these differs and an increase in tri-
and tetra-antennary glycans in PrP
Sc has been reported [12]. TSEs
also exhibit differences in PrP
Sc glycosylation patterns; Ricinus
communis agglutinin I (RCA I) binding to PrP
Sc varies between
vCJD- and sCJD-derived PrP
Sc [16] and ELISAs with RCA I and
Datura stramonium lectin (DSL) can be used to discriminate
between normal and scrapie affected tissues [17]. Differences in
glycosylation patterns of PrP, however, are not necessarily
associated with TSE pathogenesis, since the brain area from
which PrP was purified [18,19], aging [20] and cell differentiation
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protein.
The effect of glycosylation on PrP
C function remains obscure.
PrP
C N-glycosylation differences have been linked to maturation
of progenitor 1C11 neuronal cells to serotonergic or nor-
adrenergic neurons. These glycosylation differences may be linked
to some neurospecific functions of PrP
C, and the specific brain
targeting of prion strains [21]. However the effect of N-linked
glycosylation on prion strains and TSEs propagation is not yet
fully understood. Initial reports indicated it is not required for the
conversion of PrP
C to PrP
Sc [22]. More recent data from both cell
culture systems and transgenic animals also argue that diglycosyla-
tion is dispensable for PrP
Sc formation [23], whereas in a different
study, in which PMCA generated unglycosylated PrP
Sc was used
as the infectious agent, it was shown that strain tropism, as well as
other strain associated features, can be propagated in the absence
of the glycans [24]. On the other hand, a series of reports suggest
that N-linked glycosylation may modulate the conversion [25–30].
In this study, we aimed to systematically study glycosylation
differences between PrP
Sc populations purified from various TSEs,
by refining the glycotyping procedure. This was achieved by
blotting the sugar moieties that form part of the PrP
Sc glycosyl
chains in different TSEs with lectins, which enabled estimation of
the glycans N-linked to the protein. Our analysis indicates that the
abundance of specific subsets of N-linked sugars varies among
various TSEs. This variation could be linked to specific PrP
Sc
conformation required for efficient propagation by each TSE
strain, as well as to some of the TSE strains features and could be
used as an additional criterion in identification of TSE strain
origin.
Materials and Methods
Tissues and reagents
Murine (301 V), ovine and bovine BSE samples were obtained
from VLA, Weybridge, UK. Normal and scrapie ovine samples
were a gift from Dr. P. Toumazos (Veterinary Sevices Laboratory,
Nicosia, Cyprus). Nor98 ovine samples were provided by Dr S.
Benestad (National Veterinary Institute, Oslo, Norway). Sporadic
CJD brain samples were obtained from confirmed sCJD cases
[31]. Murine scrapie (RML) was generated in our laboratory. All
samples were stored at 280uC until use. Whole brains were
processed in all murine cases. Tissue from the brain stem was used
on all other occasions, unless otherwise indicated. The ovine
samples used in the study were from sheep with ARQ/ARQ
genotype. Handling of infectious material was carried out in a
safety level 3 facility. Animal work has been conducted following
relevant national and EU regulations.
Proteinase K and all chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, U.S.A.). Biotinylated lectins and ABC
complex were acquired from Vector Laboratories (Burlingame,
CA, U.S.A.). Two dimensional (2D) electrophoresis system (Zoom
IPGrunner) and all reagents required for 2D-electrophoresis were
purchased from Invitrogen (Carlsbad, CA, U.S.A.). Monoclonal
anti-PrP antibody 6H4 was a generous gift from Prionics
(Schlieren, Switzerland), while the anti-PrP antibody P4 [32] was
a gift from Dr. M.H. Groschup (INEID, Greifswald-Insel Riems,
Germany). Horseradish Peroxidase (HRP) and Alkaline Phospha-
tase (AP) conjugated Rabbit anti-Mouse IgG, Enhanced Chemi-
luminescence (ECL) and SuperSignal West Femto Maximum
Sensitivity western blotting substrates were purchased from Pierce
(Rockford, IL, U.S.A.). Prestained molecular mass markers, CDP-
star western blotting substrate and the Peptide: N-Glycosidase F
(PNGase F) kit were from NEB (Ipswich, MA, U.S.A.).
PrP
Sc purification with the guanidinium protocol. The
short purification protocol proposed by Polymenidou and
colleagues [33] was modified to allow purification of PrP
Sc from
small amounts of tissue. Ten percent w/v homogenates were
prepared in homogenization buffer [0.01 M Tris-HCl, 0.15 M
NaCl, 5 mM EDTA (pH 8.0), 1% v/v Triton X-100, 0.5% w/v
sodium deoxycholate], using a FastPrep homogenizer (Thermo
Scientific, Waltham, MA, U.S.A.). 200 ml of the homogenates
were thoroughly mixed with 100 ml of 1 M Guanidinium HCl and
incubated at 25uC for 1 h with constant agitation. The samples
were then centrifuged for 20 min at 21,0006g over 25 ml of 20%
w/v sucrose in homogenization buffer. Following centrifugation,
the pellet was resuspended in 200 ml of homogenization buffer and
treated with PK for 1 h at 37uC (murine samples: 30 mg/ml; ovine
and bovine samples: 75 mg/ml). The reaction was stopped with
the addition of PMSF to a final concentration of 5 mM and then
300 ml of cold phosphate buffered saline (PBS) and 500 ml of cold
precipitation buffer (20% w/v NaCl, 0.1% w/v N-lauroyl sarcosine
in PBS) were added. The samples were incubated for 10 min at
220uC and then centrifuged at 24,0006g for 15 min. The
supernatant was removed and the pellet was washed with 25 mM
Tris-HCl buffer (pH 8.8), 0.05% w/v N-lauroyl sarcosine, before
being centrifuged again at 24,0006g for 10 min. The supernatant
was discarded and the pellet was left overnight at 280uCi n
absolute MeOH. The sample was centrifuged again for 30 min at
24,0006g, the supernatant was discarded and the pellet was
resuspended in 2.56O’ Farrell sample loading buffer.
SDS-PAGE and electrotransfer. The samples were
incubated at 100uC for 10 min and then centrifuged for 2 min
at 24,0006g. The proteins in the samples were separated by SDS-
PAGE on 13% w/v polyacrylamide gels and then transferred to
Polyvinylidene Fluoride (PVDF) membranes (Imobillon, Billerica,
MA, U.S.A.) using a mini-transblot cell for 2.5 h at 100 V.
Two dimensional (2D) electrophoresis. 2D electrophoresis
was performed using the Invitrogen IPGrunner system. PrP
Sc was
purified with the guanidinium protocol and the final pellet was
resuspended in rehydration buffer [6 M urea, 2 M thiourea, 4% v/v
Zoom Carrier Ampholytes (pH 3–10), 2% w/v CHAPS and 60 mM
dithiothreitol (DTT)]. Isoelectric focusing was performed with 7 cm
long, pH 3–10 linear immobilized pH gradient strips. Each strip was
rehydrated overnight at 25uCi n2 0 0ml rehydration buffer containing
PrP
Sc purifiedfrom50 mgtissueandthenelectrophoresed(200 Vfor
20 min, 450 V for 15 min, 750 V for 15 min, 2000 V for 90 min).
Prior to running the second dimension, the strips were equilibrated
for 10 min in 16NuPAGE LDS sample buffer supplemented with
6 M urea, 2 M thiourea, 60 mM DTT and then for 10 min in 16
NuPAGE LDS sample buffer containing 6 M urea, 2 M thiourea
and 2.5% w/v iodoacetamide. The focused proteins were separated
on a 4–12% NuPAGE bis-tris gel, using MES buffer. Following
electrophoresis the proteins were electrotransferred on PVDF
membranes as previously outlined.
Antibody blotting. For antibody blotting, the PVDF
membrane was blocked for 1 h at room temperature with
blocking buffer [5% w/v non-fat dry milk in PBS containing
0.1% v/v Tween 20 (PBST)] and incubated overnight at 4uC with
the primary antibody diluted in blocking buffer (6H4: 0.2 mg/ml;
P4: 1:500 v/v). After washing with PBST, the membrane was
incubated for 1 h at room temperature with HRP- or AP-
conjugated rabbit anti-mouse IgG (depending on the development
method) at a concentration of 0.1 mg/ml in blocking buffer.
Immunoreactivity was visualized on x-ray films by ECL, West
Femto or CDP-star, as specified by the manufacturer.
Lectin blotting. Following electrotransfer, the membrane
was blocked with PBST, incubated for 1 h at room temperature
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I and other lectins: 10 mg/ml) and washed with PBST. The
membrane was then incubated with HRP-conjugated ABC
complex for 35 min at room temperature and washed with
PBST. Lectin binding to PrP
Sc was visualized on x-ray films using
ECL or West Femto substrate, following manufacturer’s
directions.
On some occasions the same membrane was blotted with both
the biotinylated lectin and the antibody. In that case, the
membrane was first probed with the lectin and afterwards with
the antibody, following the aforementioned protocols. To avoid
cross-reactivity between the two procedures, the membrane was
incubated for at least 48 h in PBST prior to antibody incubation
and loss of previous signals was verified by long exposures of the
membrane to x-ray films. To visualize the bound antibody, AP-
conjugated secondary antibody and CDP-star reagent were used.
Densitometric analysis. Blots were scanned and the
intensities of the bands that corresponded to the di- and the
monoglycosylated forms of PrP
Sc were estimated using ImageJ
software (v 1.40 g, available at http://rsbweb.nih.gov/ij/
download.html). For densitometric analysis only exposures
within the linear range of the x-ray film were used. To facilitate
comparisons, the IODl/IODab ratio (IODl: integrated optical
density of the lectin reactive band; IODab: integrated optical
density of the antibody reactive band) was calculated for both
lectins and both glycosylated forms of PrP
Sc. Unless otherwise
indicated, the IODl and the IODab were calculated from x-ray
films developed with identical methods and exposed for equal
times on the blots. The IODl/IODab ratio was used as an indicator
of the abundance of PrP
Sc molecules which carry ‘suitable’ glycan
moieties that permit specific lectin binding within the total PrP
Sc
population, which is recognized by the antibody. Differences in the
IODl/IODab ratios between different TSEs were tested for
statistical significance with the Mann Whitney U test. All
statistical tests were performed with data from three individuals
per group. The procedures described were performed at least
thrice to ensure reproducibility of results.
Results
To minimize the risk of non-specific binding, initial screenings for
lectin binding were performed on scrapie associated fibrils (SAFs)
preparations, which contain highly purified PrP
Sc. A number of
lectins recognizing N-linked glycans, including Solanum tuberosum
lectin (STL), which recognizes oligomers of N-acetylglucosamine,
Wheat germ agglutinin (WGA), which preferentially recognizes
dimers and trimers of N-acetylglucosamine, and Maackiaamurensis
lectin II (MAL II), which recognizes sialic acid in an (aR2,3)
linkage, either failed to produce any signal (STL, MAL II) or
produced a very faint one (WGA recognized the di-glycosylated
form). Others, including Concanavalin A, which recognizes a-
linked mannose, did not recognize PrP
Sc and produced high non-
specific binding. Results from these initial screenings are summa-
rized in Supplementary Table S1. Of the positively reacting lectins,
the ones producing the most specific signal were Datura
stramonium agglutinin (DSL), which recognizes (bR1,4) linked
N-acetylglucosamine oligomers and Ricinus communis agglutinin I
(RCA I), which recognizes oligosaccharides ending in galactose and
N-acetylgalactosamine (Fig S1 and data not shown).
We next used DSL and RCA I to probe guanidinium protocol-
purified PrP
Sc. The guanidinium protocol was devised due to the
limited tissue availability, which prohibited the use of SAF
preparations. Lectin specificity for PrP
Sc was confirmed by
applying the guanidinium purification and blotting protocols on
simultaneously processed normal and TSE-affected tissue. No
proteins were probed by the antibody or the lectins in the normal
sample, as opposed to the TSE affected sample, in which the
lectins recognized di- and monoglycosylated PrP
Sc (Fig S2C).
2D electrophoresis. To further validate lectin specificity for
PrP
Sc in guanidinium protocol treated preparations we performed
2D electrophoresis. The enhanced resolution afforded by this
method minimizes the probability of bands overlapping, which
could occur in one dimensional electrophoresis and lead to false
positive results. PrP
Sc purified with the guanidinium protocol from
a representative ovine scrapie preparation was analyzed by 2D
electrophoresis and then probed with the monoclonal antibody
6H4 and the lectins. Upon blotting with 6H4 a cluster of
immunoreactive spots covering a range of apparent molecular
masses corresponding to the PK treated di-, mono- and
unglycosylated forms of PrP
Sc was recognized. The isoelectric
points (pIs) of this cluster of spots ranged from ,5 to 8 (Fig 1A).
When identically prepared membranes were blotted with the two
lectins, a cluster of spots with apparent molecular masses
corresponding to the di- and the monoglycosylated forms of PK
treated PrP
Sc was obtained with both lectins. The DSL-reacting
cluster of spots was smaller in area than the 6H4-reacting one, but
had an almost similar pI range (,5–8) distribution (Fig 1A, B, D).
RCA I, recognized a smaller cluster of spots than both DSL and
6H4. The pIs of the spots in this cluster ranged between ,6.5 and
8. (Fig 1A, C, D). The resolution of the 2Ds was not high enough
Figure 1. Two dimensional electrophoresis and lectin blotting
of PrP
Sc purified with the guanidinium protocol. PrP
Sc was
purified from a representative ovine scrapie sample with the
guanidinium protocol, resolved in 2D and blotted with 6H4 (A), DSL
(B), and RCA I (C), as outlined in ‘Materials and Methods’. Squares (&):
diglycosylated PrP
Sc; bullets ($): monoglycosylated; arrows (R): 32, 25,
16.5 kDa molecular mass markers. (D) Superimposition of the cluster of
DSL- (red line) and RCA I- (blue line) reactive spots on the cluster of
6H4-immunoreactive spots (black line).
doi:10.1371/journal.pone.0005633.g001
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with the antibody and the lectins showed that the lectin-reacting
proteins are a subpopulation of the antibody-reacting ones, as
evidenced in Fig 1D. Thus 2D blotting proved that DSL and RCA
I specifically blot PrP
Sc and that these lectins recognize a subset
only of 6H4 reacting PrP
Sc molecules.
Ovine scrapie and bovine BSE preparations. We next
applied the method on a variety of TSE affected samples. When
ovine scrapie (Fig 2; Lanes 1, 3, 5) and bovine BSE PrP
Sc (Fig 2;
Lanes 2, 4, 6) were purified and probed with 6H4, the three-
banded pattern was obtained. As expected, unglycosylated PrP
Sc
migrated faster in the bovine BSE sample (Fig 2A). Upon lectin
blotting, the lectins recognized di- and monoglycosylated PrP
Sc in
both bovine BSE and ovine scrapie samples (Fig 2B–C).
Densitometric analysis was performed as described in ‘Materials
and Methods’ and the IODl/IODab ratio was found on all
occasions to be lower in the bovine BSE samples (Fig 2D). These
differences were more pronounced in the RCA I blotted
monoglycosylated PrP
Sc bands; the IODl/IODab of the ovine
scrapie samples was ,8-fold greater than the IODl/IODab of the
bovine BSE samples. Significantly different (P,0.05) IODl/IODab
ratios were obtained on all comparisons, except for RCA I blotting
of diglycosylated PrP
Sc.
In addition to differences in the intensities of the bands, small
differences in the apparent molecular mass of monoglycosylated
PrP
Sc were noticed following antibody and DSL blotting. With
antibody blotting, the monoglycosylated PrP
Sc band was rather
diffuse and displayed the same apparent molecular mass in both
ovine scrapie and bovine BSE samples. Following DSL blotting,
monoglycosylated PrP
Sc was sharper in both ovine scrapie and
bovine BSE samples and the lectin appeared to have a preference
for different subpopulations of 6H4-reactive monoglycosylated
PrP
Sc; DSL recognized the higher apparent molecular mass region
of the 6H4-reacting monoglycosylated PrP
Sc band in ovine scrapie
samples, whereas in bovine BSE samples it blotted the medium
apparent molecular mass region of the 6H4-reacting monoglyco-
sylated PrP
Sc band. To better exhibit this preference for the higher
molecular mass subpopulation of monoglycosylated PrP
Sc in ovine
Figure 2. Ovine scrapie and bovine BSE. PrP
Sc was purified from ovine scrapie (Lanes 1, 3, 5) and bovine BSE (Lanes 2, 4, 6) samples with the
guanidinium protocol and probed with 6H4 (A), DSL (B), and RCA I (C), as outlined in ‘Materials and Methods’. Equal amounts of starting material were
loaded in all lanes and equal exposure times were used for all three panels. Squares (&): diglycosylated PrP
Sc; bullets ($): monoglycosylated; arrow
(R): 25 kDa molecular mass marker. The remaining non-marked lectin reactive glycoproteins should be considered as interfering glycoproteins. (D)
Densitometric analysis of the diglycosylated and the monoglycosylated forms of PrP
Sc. IODl/IODab is the ratio of the IOD of the lectin- blotted band
versus the IOD of the antibody-blotted band, estimated as described in ‘Materials and Methods’. Columns represent the mean IODl/IODab and error
bars the SEM from three individuals. *P,0.05.
doi:10.1371/journal.pone.0005633.g002
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Sc from two
representative ovine scrapie samples was electrophoresed and
electrotransferred. Following electrotransfer, the membrane was
cut and one part blotted with 6H4 and the other with DSL.
Meticulous alignment of the two parts revealed the differences in
apparent molecular weight of monoglycosylated PrP
Sc following
antibody or lectin staining (Fig S3).
Ovine scrapie and BSE preparations. In guanidinium
protocol preparations of ovine BSE samples virtually no signal
was obtained for the mono- and the unglycosylated forms of PrP
Sc
upon antibody (6H4) blotting using standard sensitivity substrate
(ECL, Fig 3A; Lane 3). On the contrary, equal loads of parallel-
processed ovine scrapie samples produced the typical three-banded
pattern (Fig 3A; Lanes 1, 2). To visualize the antibody reactive
mono- and unglycosylated PrP
Sc bands in ovine BSE preparations,
the blots had to be developed with a higher sensitivity substrate
(SuperSignal WestFemto, Fig3D). As opposed to antibodyblotting,
PrP
Sc from ovine BSE samples was recognized by the lectins and a
clear signal was obtained even with ECL (Fig 3; Lanes 3, 6, 9).
Due to the extremely faint ECL-developed, antibody-blotted
monoglycosylated PrP
Sc band in the ovine BSE samples,
densitometry data from the West Femto-developed antibody blots
was used to calculate the IODl/IODab ratio for all samples in the
densitometric analysis (Fig 3E). The analysis revealed a statistically
significant (P,0.05) difference in the intensity of the RCA I
reactive monoglycosylated band between the BSE and scrapie
challenged ovine samples.
Similarly to the results obtained in ovine scrapie and bovine
BSE samples, DSL-blotted, ovine BSE monoglycosylated PrP
Sc
displayed lower apparent molecular mass than ovine scrapie
monoglycosylated PrP
Sc (Fig 3B).
Murine scrapie and BSE preparations. Similar analyses
were performed on murine scrapie (RML) and BSE (301 V)
samples (Fig 4; Lanes 1, 3, 5 and 2, 4, 6 respectively). The blots
were probed with 6H4 and the three-banded pattern for PrP
Sc was
obtained (Fig 4A) on all samples. Monoglycosylated PrP
Sc in
murine BSE samples migrated slightly faster than its counterpart
in murine scrapie samples. Upon lectin blotting of the same
preparations, very faint blotting was produced in murine scrapie,
as opposed to murine BSE samples (Fig 4B, C; Lanes 3–6). These
differences in blotting were evident in the densitometric analysis,
where statistically significant differences emerged on most
comparisons (Fig 4D). Faint staining of murine scrapie samples
hampered thorough analysis of differences in the apparent
molecular masses of the lectin-blotted bands. However, lectin
blotted bands were sharper than the corresponding antibody
blotted ones, implying a preference of the lectins for specific
subsets of PrP
Sc molecules (Fig 4 A, B).
Figure 3. Ovine BSE. 6H4 (A), DSL (B), and RCA I (C) blotting of PrP
Sc purified from ovine scrapie (Lanes 1, 2, 4, 5, 7, 8, 10, 11) and ovine BSE (Lanes 3,
6, 9, 12) with the guanidinium protocol and developed with ECL, as described in ‘Materials and Methods’. Equal amounts of starting material were
loaded in all lanes and equal exposure times were used for all three panels. (D) Development of 6H4 blotted lanes with a higher sensitivity substrate
(West Femto, Lanes 10, 11, 12). Squares (&): diglycosylated PrP
Sc; bullets ($): monoglycosylated; arrow (R): 25 kDa molecular mass marker. The
remaining non-marked lectin-reactive glycoproteins should be considered as interfering glycoproteins. (E) Densitometric analysis of the
diglycosylated and the monoglycosylated forms of PrP
Sc. The IODl/IODab ratio was calculated as outlined in ‘Materials and Methods’, but the IODab
following development with the high sensitivity substrate and thus a different exposure time was used. Columns represent the mean IODl/IODab and
error bars the SEM from three individuals. *P,0.05.
doi:10.1371/journal.pone.0005633.g003
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In this study, we intended to determine whether differences
occur in the composition of N-linked sugar chains of PrP
Sc
populations derived from different TSEs. To address this question,
we blotted PrP
Sc purified from tissue affected with different TSEs
with monoclonal antibodies and lectins. Lectins are carbohydrate-
binding proteins, which recognize and bind to specific sugar
moieties with high specificity [34].
We initially screened a panel of lectins for their ability to
recognize PrP
Sc in western blots. From this screening two lectins
with affinity for PrP
Sc emerged, namely DSL and RCA I. DSL
recognizes repeating N-acetyllactosamine [Gal b(1R4) GlcNAc]
oligomers, whereas RCA I binds to terminal galactose (Gal) or N-
acetylgalactosamine (GalNAc). Since PrP
Sc from naturally occur-
ring TSEs contains complex-type sugars composed of multiple
units of lactosamines, which are multimers of Gal b(1R4) GlcNAc
[12–14], DSL and RCA I were expected to bind PrP
Sc.I n
agreement with that, DSL and RCA I were previously reported to
bind PrP in ELISAs [16,17]. Our initial findings were confirmed
by a series of results, including: i) blotting of PrP
Sc from highly
purified PrP
Sc preparations (SAFs) from a multitude of species with
the lectins, (Fig S1), ii) lack of lectin blotting in PK treated
preparations from normal animals (Fig S2C), and in PNGase and
PK treated preparations of TSE affected animals (data not shown),
iii) colocalization of lectins and antibody (6H4) reactivity following
2D electrophoresis of purified PrP
Sc (Fig 1). These data further
confirm that DSL and RCA I recognize specifically PrP
Sc
subpopulations and not other copurifying host glycoproteins.
Once the protocols for PrP
Sc purification and lectin blotting
were devised, we studied the glycosylation differences in PrP
Sc
populations purified from tissues affected with various TSEs. We
found that DSL and RCA I blotted PrP
Sc in all samples. This
result indicates that the purified PrP
Sc populations contain similar
glycan species. However, blotting intensity of the glycosylated
bands varied, suggesting that the abundance of each particular
type of glycan in PrP
Sc populations differs among various TSEs.
Lectin blotting following PrP
Sc purification with the guanidi-
nium protocol was also used to study glycosylation differences
between classical and atypical (Nor98) scrapie cases (Fig S4).
Results from lectin blotting of Nor98 scrapie PrP
Sc were difficult to
interpret, but appear to be in agreement with recently published
data [35,36] and although non conclusive, demonstrate that PrP
Sc
glycosylation pattern is different than classical scrapie. The
Figure 4. Murine scrapie and BSE. 6H4 (A), DSL (B) and RCA I (C) blotting of PrP
Sc purified from murine scrapie (Lanes 1, 3, 5) and murine BSE
(Lanes 2, 4, 6) samples, following the guanidinium protocol. Equal amounts of starting material were loaded in all lanes and equal exposure times
were used for all three panels. Squares (&): diglycosylated PrP
Sc; bullets ($): monoglycosylated; arrow (R): 25 kDa molecular mass marker. (D)
Densitometric analysis of the diglycosylated and the monoglycosylated forms of PrP
Sc. The intensity of the band of the di- and the monoglycosylated
PrP
Sc was estimated and the IODl/IODab ratio was calculated, as outlined in ‘Materials and Methods’. Columns represent the mean IODl/IODab and
error bars the SEM from three individuals. *P,0.05.
doi:10.1371/journal.pone.0005633.g004
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Sc fragments with
apparent molecular masses ranging from 21 to 31 kDa in PK
treated Nor98 samples has already been suggested. These are
proposed to arise from the glycosylation of PrP
Sc fragments with
molecular masses of 18 and 23 kDa [35]. In our study, lectin
reactivity was observed in this range of molecular masses and
possibly some of the observed bands could correspond to these
Nor98 PrP
Sc fragments.
A P4 reactive, glycosylated and PK resistant PrP
Sc fragment,
with an apparent molecular mass of 33 kDa has already been
described in Nor98 samples [36]. This fragment was most
probably recognized by both DSL and RCA I, as evidenced by
the P4 and lectins reactivity of a 33 kDa band (Fig S4B, D open
diamond). Another glycosylated and PK resistant PrP
Sc fragment
with an apparent molecular mass of 24 kDa, which bears the L42,
but not the P4 epitope, has also been described in Nor98 samples
[36]. Since the L42 antibody was not used in our study, positive
identification of this fragment among the lectin reacting bands was
difficult. However both lectins and mostly DSL recognize a band
with an apparent electrophoretic mobility of approximately
22 kDa, which could correspond to the 24 kDa PrP
Sc fragment
(Fig S4B, D solid diamond). Interestingly, both lectins and
especially RCA I clearly recognized two bands with molecular
masses ranging between 6 and 8 kDa (Fig S4B, D, open squares).
These two bands may correspond to C-terminal PrP
Sc fragments
encompassing the two glycosylation sites, but not the P4 epitope.
It is important to stressthat dueto limitations of our experimental
approach, we cannot rule out the possibility that any of the bands
that were associated with PrP
Sc in Nor98 samples are in fact
interfering glycoproteins with an electrophoretic mobility similar to
some PrP
Sc fragments. These results await confirmation by mass
spectrometry and/or amino acid sequencing, which due to limited
availability of tissue have not yet been performed.
PrP
Sc which is purified from different species is heterogeneous
with regard to sugar content [12–14]; each subpopulation of PrP
Sc
molecules contains different N-linked sugars, and thus may or may
not be recognized by the lectins in use. This recognition is only
possible if the PrP
Sc molecule carries the ‘suitable’ sugar moiety for
the lectin to bind. This was evidenced in our results by the
differences in signal intensity and electrophoretic mobility of the
bands that were recognized by the antibody and the lectins.
Lectins recognize a subpopulation only within the total PrP
Sc
population. The strong signal that was obtained for monoglyco-
sylated PrP
Sc in ovine BSE samples following lectin-blotting,
indicates that this preparation is enriched in a lectin-reacting PrP
Sc
subpopulation, leading to strong reactivity with the lectins, in spite
of the poor antibody reactivity. Similarly, the differences in
apparent molecular mass of antibody- and lectin-reactive bands
(Fig 2, 3 and S3) should be attributed to the fact that only some of
the purified PrP
Sc molecules are blotted by the lectins. As a result,
DSL binds only part of the monoglycosylated PrP
Sc molecules and
the corresponding band appears sharper than the antibody blotted
one. In agreement with these observations, part of the 6H4
immunoreactive cluster of spots is also recognized by the lectins in
2D blots (Fig 1).
It is important to point out that different PrP
Sc purification
protocols may be biased towards different PrP
Sc subpopulations
and possibly permit co-purification of interfering glycoproteins.
Four different purification protocols were evaluated in our study:
the short purification process [33], the sodium phosphotungstate
protocol (NaPTA) [37], the SAF preparations [38] and the
guanidinium protocol. Although all four purification protocols
purified PrP
Sc with comparable glycoform ratios (Fig S2D), the
presence of interfering glycoproteins, evidenced by lectins blotting,
as well as initial tissue requirements dictated the choice of the
guanidinium protocol over the other purification protocols. The
short purification and the NaPTA protocols failed to produce
PrP
Sc with adequate purity (Fig S2A, B). The guanidinium
protocol was preferred over the SAF preparations, due to its
higher yield and significantly lower starting material, time and
hardware requirements. Nevertheless, SAF preparations could
produce optimal results and ideally when there is no tissue
limitation, SAF preparations should be preferable. Interestingly, in
preliminary experiments with SAF preparations from human
vCJD, bovine BSE, human sCJD and ovine scrapie samples, the
lectins recognized only –or mostly- diglycosylated PrP
Sc,a s
opposed to human sCJD and ovine scrapie, in which both the
di- and the monoglycosylated forms were recognized (Fig S1 and
data not shown).
Our experimental setup permits the analysis of the glycosylation
pattern of PK resistant PrP, which amounts to a large proportion (at
least 45–65%) of total PrP
Sc [39]. To our knowledge, glycosylation
remains unaltered throughout the conversion of PrP
C to PrP
Sc;
therefore the observed differences in PrP
Sc glycosylation between
the various TSEs could be linked to differences in glycosylation of
PrP
C following TSE infection, or to the preferential conversion of
specific subpopulations of PrP
C to PrP
Sc.
Perturbation of the glycosylation machinery in TSE affected
cells, which could affect the glycosylation of PrP and of other
proteins, has already been proposed [12,40,41]. DNA array
analysis in GT1 cells indicates a change in the expression pattern
of genes governing the synthesis of glycosaminoglycans [42],
however the majority of data from DNA arrays in murine scrapie
models advocate against major modification of the expression
pattern of glycosylation related genes [43–45]. A recent study
focused on the expression pattern of glycosylation-related genes in
the brains and spleens of Tg338 mice, intracerebrally challenged
with a mouse adapted scrapie strain [46]. At terminal stage, eight
genes were overexpressed in the brain and five were differentially
expressed in the spleen. Interestingly, the biological effects linked
to the reported overexpression of two genes (St6gal1 and Mgat3)d o
not match the observed differences in prion protein glycosylation
[12]. The authors argue that these genes are not necessarily
upregulated in all cells and that the observed expression alterations
may not be involved in the disease pathogenesis, but could reflect
disease-associated processes, such as inflammation [46]. Taking
into consideration these data, it cannot be ruled out that the
observed differences in PrP
Sc glycosylation are the result of
preferential conversion of select PrP
C glycoforms to PrP
Sc.
Despite N-linked glycosylation is not evidently required for the
conversion of PrP
C to PrP
Sc [22,23] mounting evidence suggests
that sugar chains may be important in the modulation of the
conversion, affecting the propagation between different species as
well as the appearance of strains. Although the primary structure
of the protein is a key determinant for the conversion of PrP
C to
PrP
Sc [47,48], glycosylation may also play a secondary role, as
shown in both in vitro and in vivo experiments [26–28]. PrP
Sc itself
can dictate the formation of strain-specific PrP
Sc glycoforms, even
if unglycosylated [24], however the final PrP
Sc glycopattern can be
influenced by the cell and significantly altered by changes in the
glycosylation state of PrP
C [29]. In agreement with this, a recent
study indicated that in CJD PrP
Sc glycoforms ratio significantly
correlated with the genotype at codon 129 of the prion protein
gene [49] Thus, strain-specific PrP
Sc glycosylation profiles could
arise from a complex interaction between PrP
C, PrP
Sc and the cell,
and may indicate the cellular compartment in which the strain-
specific formation of PrP
Sc occurs [29]. More recent data advocate
on the importance of PrP
C glycoforms in in vitro conversion systems
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C glycoforms
appear to control the efficiency of prion formation in a species-
specific manner [26]. In another in vivo study, the importance of
host PrP
C glycosylation was utterly exalted by the findings that
transgenic mice with restricted N-linked glycosylation display
striking differences in susceptibility with different prion strains,
including complete resistance in some occasions [28].
Our results also point towards the occurrence of a complex
interaction between PrP
Sc, host PrP
C and tissue compartment. We
observed that in both ovine and murine BSE PrP
Sc, the total
monoglycosylated PrP
Sc population is enriched in RCA I rather
than DSL reacting subpopulations, as opposed to bovine BSE
PrP
Sc populations, in which DSL and RCA I reacting mono-
glycosylated PrP
Sc subpopulations were equally represented (Fig
S5). If the species barrier and the strain phenomena are indeed the
result of the effect of different PrP
C conformational requirements
by PrP
Sc [47], then these findings could be an indication that upon
propagation of bovine BSE to new hosts, i.e. mice and sheep, the
strain adapts and ‘selects’ a different portfolio of PrP
C molecules,
with a different glycan profile and possibly a different structure
which facilitates propagation in the new hosts. Taking under
consideration PrP
C glycosylation differences in the various brain
regions, as well as at the cell level, the already proposed link
between prion strain neurotropism and PrP
C glycosylation [19,50]
appears appealing, despite already having been debated [51]. It is
important, however, to point out that most studies on the influence
of PrP
C and PrP
Sc on TSE transmission rely on quantitative data
on the relative abundance of the di-, mono- and unglycosylated
forms of the protein, without taking under consideration the
nature and abundance of the N-linked glycans. We believe that
sequencing of PrP glycans purified from different brain areas in
combination with lesion profiling studies could add insight into the
phenomenon.
PrP
Sc purification following the guanidinium protocol, com-
bined with western blotting and lectin staining proved to be a fast
and efficient method for quick estimation of glycans N-linked to
PrP
Sc. When this method was applied on tissue samples affected
with a variety of TSEs, differences in the relative abundance of the
N-linked glycan moieties were found. Although the importance of
prion protein glycosylation for TSEs propagation is still elusive
and often debated, our findings indicate that possibly specific
subpopulations of PrP
Sc molecules, characterized by the presence
of distinct sugars, facilitate the propagation of each TSE strain.
From a practical standpoint, these differences could be useful as
additional traits for the discrimination or origin recognition of
TSE strains.
Supporting Information
Figure S1 Blotting of ovine scrapie, bovine BSE and human
sCJD SAFs with Sal1, DSL and RCA I. SAFs were prepared from
ovine scrapie (Lanes 1, 4, 7), bovine BSE (Lanes 2, 5, 8) and sCJD
(Lanes 3, 6, 9) samples and probed with a polyclonal anti-PrP
antibody (Sal1, A), DSL (B) and RCA I (C), as described in
‘Materials and Methods’. Equal amounts of starting material were
loaded in all lanes and equal exposure times were used for all three
panels. Squares (&): diglycosylated PrP
Sc; bullets ($): mono-
glycosylated; arrow (R): 25 kDa molecular mass marker.
Found at: doi:10.1371/journal.pone.0005633.s001 (0.66 MB TIF)
Figure S2 Comparison of three PrP
Sc purification protocols. A
normal (Lanes 1, 3, 5) and an ovine scrapie sample (Lanes 2, 4, 6)
were treated with the NaPTA (A), short (B) or guanidinium
protocols (C) and then electrophoresed, electrotransferred and
blotted with 6H4, DSL and RCA I, as described in ‘Materials and
Methods’. (D) densitometric analysis of the PrP
Sc glycoforms
following 6H4 staining. Each point represents the percentage of
immunoreactivity of the di- and monoglycosylated forms of the
protein, versus total immunoreactivity (di-, mono- and unglyco-
sylated forms). Despite all three purification protocols provide
PrP
Sc with comparable purity and glycoform ratios, only the
guanidinium protocol is compatible with lectin staining, as
evidenced by the interfering glycoproteins recognized by the
lectins following either the NaPTA or the short purification
protocol. Equal amounts of starting material were loaded in all
lanes for each purification protocol. Solid squares (&): diglycosy-
lated PrP
Sc; bullets($): monoglycosylated; arrowheads(c): inter-
fering glycoproteins; arrow(R): 25 kDa molecular mass marker;
open square(%): NaPTA purified PrP
Sc; open diamond(e): short
protocol purified PrP
Sc; solid diamond(X): Guanidinium purified
PrP
Sc.
Found at: doi:10.1371/journal.pone.0005633.s002 (1.79 MB TIF)
Figure S3 Small differences in the apparent molecular mass of
the monoglycosylated PrP
Sc band emerge following 6H4 and DSL
blotting. PrP
Sc was purified with the guanidinium protocol from
two representative ovine scrapie samples and then electropho-
resed, electrotransferred and probed with 6H4 (A) or DSL (B) as
described in ‘Materials and Methods’. The DSL-probed, mono-
glycosylated PrP
Sc band is sharper and corresponds to a portion
only of the 6H4 probed monoglycosylated PrP
Sc band, with higher
apparent molecular mass. This difference in the apparent
molecular masses should be attributed to the binding of the lectin
on a subpopulation of the PrP
Sc molecules presenting the ‘suitable’
sugar moiety for recognition. On the contrary, the antibody binds
all the PrP
Sc molecules present. Equal amounts of starting material
were loaded on all lanes. Squares: diglycosylated PrP
Sc; bullets
($): monoglycosylated; arrow(R): 25 kDa molecular mass
marker, left bracket ({): size range of monoglycosylated PrP
Sc
after 6H4 blotting; right bracket(}): size range after DSL blotting.
Found at: doi:10.1371/journal.pone.0005633.s003 (0.46 MB TIF)
Figure S4 Atypical (Nor98) scrapie. P4 (A, C), DSL (B) and
RCA I (D) blotting of PrP
Sc purified from the cortex of classical
(Lane 1) and Nor98 scrapie samples (Lanes 2–5) with the
guanidinium protocol. Equal amounts of starting material were
loaded in all lanes. Each membrane was first probed with one
lectin (DSL, panel B; RCA I, panel D) and then with P4 (panels A,
C respectively), as described in ‘Materials and Methods’. The
different pattern in classical scrapie samples in this figure,
compared to the one in the other figures, should be attributed to
the different part of the brain used. Solid squares (&):
diglycosylated PrP
Sc (classical scrapie); bullets ($): monoglycosy-
lated (classical scrapie); open diamonds (e): PrP
Sc associated bands
(Nor 98 samples); solid diamonds (X): putative PrP
Sc associated
bands (Nor 98 samples); open squares (%): putative lectin-reacting,
C-terminal PrP
Sc fragments; arrows (R): 25, 16.5 and 6.5 kDa
molecular mass markers. The remaining, non marked lectins-
reactive bands, most probably are interfering glycoproteins.
Found at: doi:10.1371/journal.pone.0005633.s004 (2.33 MB TIF)
Figure S5 Glycosylation differences among bovine, ovine and
murine BSE. The abundance of RCA I and DSL reacting PrP
Sc
subpopulations in bovine BSE (BSE), ovine BSE (oBSE) and
murine BSE (mBSE), guanidinium protocol-purified PrP
Sc was
estimated by computing the IODRCA I/IODDSL [integrated
optical density of the RCA I reactive band (IODRCA I)/integrated
optical density of the DSL reactive band (IODDSL)] ratio for each
of the di- and monoglycosylated PrP
Sc bands, as well as for the
total (di- +monoglycosylated PrP
Sc bands). PrP
Sc populations in
ovine and murine BSE appear to be enriched in RCA I reactive
PrP
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particularly evident in monoglycosylated PrP
Sc. Columns repre-
sent the mean IODRCA I/IODDSL and error bars the SEM from
three individuals.
Found at: doi:10.1371/journal.pone.0005633.s005 (1.00 MB TIF)
Table S1 Lectins used in the study. All the lectins were diluted to
10 mg/ml, except for DSL (6 mg/ml) and checked for PrP
Sc
recognition on SAFs or guanidinium preparations, as outlined in
‘Materials and Methods’. (-) indicates lack of PrP
Sc recognition, as
assessed by the apparent molecular masses of the bands.
Abbreviations used: mBSE: murine BSE; Sc: ovine scrapie; sCJD:
human sporadic CJD; vCJD: human variant CJD; BSE: bovine
BSE; mSc: murine scrapie; oBSE: ovine BSE; Nor98: atypical
Nor98 ovine scrapie.
Found at: doi:10.1371/journal.pone.0005633.s006 (0.05 MB
DOC)
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